J. Stoddard

Burden of opioid use for pain management among adult herpes zoster patients in the US and the potential impact of vaccination

J. Meyers, K. Hicks, Jessica K. DeMartino, 2022, Human vaccines & immunotherapeutics.

Development of a novel patient-reported outcome measure to assess signs and symptoms of COVID-19

J. Sadoff, S. Fehnel, A. Slagle, 2022, Journal of Patient-Reported Outcomes.

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

H. Schuitemaker, M. Robb, P. Goepfert, 2022, The New England journal of medicine.

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

A. Borobia, H. Schuitemaker, Andrew Gibson, 2022, The Lancet Infectious Diseases.

Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial

Y. Liu, J. Sadoff, S. Fehnel, 2023, Journal of Patient-Reported Outcomes.

Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States.

V. Shinde, S. Talbird, B. Rosen, 2021, Vaccine.